Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Molecular Assay System Validated for Opportunistic Virus Infections

By LabMedica International staff writers
Posted on 31 Oct 2012
Laboratory-developed real-time polymerase chain reaction (PCR) protocols have been implemented for the molecular diagnosis of opportunistic DNA virus infections. More...


The validity of a duplex real-time PCR protocols for viral DNA have been improved by using an extraction and amplification control that allows for the monitoring of the molecular diagnostic process.

Virologists at the Pierre and Marie Curie University (Paris, France) tested 152 clinical samples including 77 whole bloods, 30 bronchoalveolar lavages, 28 viral transport medium containing mucocutaneous swabs, 12 urine, and 5 stool samples. The genomes of herpes simplex virus (HSV), varicella-zoster virus (VZV), human cytomegalovirus (CMV), Epstein–Barr virus (EBV), BK virus (BKV), and adenovirus (AdV) were investigated.

The Simplexa extraction and amplification control (SEAC) set (Eurobio; Courtaboeuf, France) was evaluated in this study. This internal control corresponds to a 577-base pair DNA fragment derived from the gene encoding ribulose-1,5-bisphosphate carboxylase oxygenase large unit N-methyltransferase of the plant Arabidopsis thaliana. This is a noncompetitive internal control with its own mix, containing primers and a Quasar 670 labeled-probe specifically designed for its amplification (Biosearch Technologies; Novato, CA, USA). Viral DNA amplifications were performed on the Light cycler LC480 system (Roche Diagnostics; Meylan, France) using laboratory-developed real-time PCR assays based on hydrolysis probe technology implemented in the laboratory for virological diagnosis activity.

The SEAC results showed high reproducibility with a mean crossing point (Cp) value of 31.08 ± 1.44, and were not influenced by the virus-specific PCR performed or the type of clinical specimen tested. The use of the SEAC did not influence the results of the different virus-specific PCRs compared to other systems. The SEAC in the DNA extracts showed high stability during storage at both +4 °C and -20 °C.

The authors concluded that the use of the commercial SEAC is simple, straightforward, and beneficial. It makes not only the detection of opportunistic viruses in clinical samples more convenient and cost-effective, but it ensures also the effectiveness of the whole molecular process implemented in the laboratory to perform the diagnosis of viral infections. The SEAC provides a reliable option to improve the diagnosis of opportunistic viral infections in laboratories using in-house real-time PCR assays. The study was published in the October 2012 edition of the Journal of Virological Methods.

Related Links:
Pierre and Marie Curie University
Eurobio
Biosearch Technologies


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.